Resources
Filter by Topic
- Articles
Joseph Menzin, PhD, discusses the risks and rewards of fast-tracked COVID-19 studies.
- Press Releases
BHE, a leading healthcare analytics company, has announced the formation of its Strategic Advisory Board. The initial appointments include Peter Neumann, ScD, Director of the...
- Articles
Matthew Sussman, BHE's VP of Modeling & Strategy Services, discusses the use of remdesivir for COVID-19 patients and the risks and rewards of fast tracking...
- News & Events
Matthew Sussman, BHE's VP of Modeling & Strategy Services, discusses exploring strategies for facilitating access to the timely patient data and analysis needed for successful...
- News & Events
We formed a partnership with Premier Inc. to streamline data analytics and more quickly uncover strategies to improve patient care. Researchers and data scientists will...
- Press Releases
Boston Health Economics (BHE), a leading healthcare self-service analytics company, and Premier Healthcare Solutions, Inc. (Premier), a leading healthcare improvement company, are joining forces to...
- Articles
Healthcare IT Today article from Panalgo Founder and Executive Chairman, Joseph Menzin, PhD.
Pregnancy rates and outcomes in women with and without MS in the United States
Authors: MK Houtchens, NC Edwards, G Schneider, K Stern, AL Phillips Published: Neurology, 2018. Click here for the article.
Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives
Authors: Matthew Sussman, Jennifer Benner, Peter Neumann, Joseph Menzin Published: Cephalalgia, 2018. Click here for the full article.
Predictors of All-Cause Healthcare Payments Among Patients with Treatment-Resistant Major Depressive Disorder
Authors: M Sussman, A O’Sullivan, A Shah, J Menzin, M Olfson Published: Value in Health, ISPOR 2018 Click here for the article.
Real-World Bleeding Risks in Non-Valvular Atrial Fibrillation Patients with Heart Failure: Contemporary HER Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban, and Warfarin.
Authors: Iris Lin, Ruslan Horblyuk, Jack Mardekian, Sang Hee Park, Shital Kamble, Melissa Hamilton, Younos Abdulsattar, William Petkun, Joseph Menzin, and Gregory Y Lip Published: Circulation,
Comorbidity in US patients with multiple sclerosis
Authors: N Edwards, M Munsell, J Menzin, A Phillips Published: Patient Related Outcome Measures, 2018 Click here to view.
Development and validation of a claims-based measure as an indicator for disease severity in patients with multiple sclerosis treated with disease-modifying drugs
Authors: Michael Munsell, Molly Frean, Joseph Menzin, and Amy L. Phillips Published: BMC Neurology Click here for the article.
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization